United States of America Anticoagulants Market Size, Share, and COVID-19 Impact Analysis, By Application (Atrial Fibrillation/Myocardial Infarction (Heart attack), Deep Vein Thrombosis, Pulmonary Embolism, and Others), By Drug Category (Vitamin K Antagonist, Direct Thrombin Inhibitors, Novel Oral Anticoagulants (NOACs), Heparin, and Others), By Route of Administration (Oral Anticoagulants and Injectable Anticoagulants), and United States of America Anticoagulants Market Insights, Industry Trend, Forecasts to 2035
Premium Report Details
Base Year:
2024
Tables & Figures:
89
Pages:
220
Countries covered:
1
Companies covered::
17
Forecast CAGR:
5.31%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies